INTRODUCTION
Urinary calculi are the third prevalent disorder in the urinary system. It is calculated that nearly 10% of the population of the industrialized world is affected by urinary tract stone disease. Kidney stones account for 0.5 to 1.9 % of clinical cases in industrialized countries [1] . Urinary calculi may cause obstruction, hydronephrosis, infection and hemorrhage in the urinary tract system [2] . Since the mid-1980s, management of nephrolithiasis has been by non-surgical methods such as lithotripsy, fiberoptic technology, electrical sparks and laser techniques, which provide therapeutic alternatives to surgery. Thus, the requirement for surgical intervention for removal of kidney stones has almost been reduced. Although, these procedures are cost-effective, they have side effects and may cause severe complications. Many Indian plants are thought to be useful antiurolithiatic agents [2, 3] . Hence, plants are sometimes evaluated for possible antilithiatic.
Melia azedarach Linn (meliaceae) popularly known as media dubia Cav, Indian lilac and Persian lilac, is found in most of the tropical and sub-tropical countries, including India, China, Japan .Philippines, Brazil, Argentina, as well as African and Arab countries, and the United States of America [4] . Chemical constituents of the leaves include nimbinene, quercetin-3-0-brutinoside, kaempferol-3-0-b rutinoside, rutin and kaempferol-3-L-rhamno-Dglucoside, nimbinene, azaridine , meliacin and quercetin [5, 6] . A literature survey revealed that M. azedarach Linn also contains glycerol 1, 3-bisundec-9-enoate 2-dodec-9-enoate and glycerol tris-tridec-9-enoate, dipentadecyl ketone, flavonoids, limmonoids, tannis, sterols, saponines and triterpenoids which possibly contribute to its various uses in tradition medicine [7, 8] .
The present investigation was designed to evaluate the anti-urolithiatic property of the aqueous and ethanol extract of Melia azedarach Linn leaves in ethylene glycol-induced calcium oxalate urolithiasis in male albino rats.
EXPERIMENTAL Collection of plant material
The leaves of Melia azedarach were collected from the botanical garden at the Campus of Padmavathi College of Pharmacy, Dharmapuri in June, 2011. The plant was identified and authenticated by Dr. P. Jayaraman, Botanist, Director of Plant Anatomy Research Centre (PARC), Chennai, India. A voucher specimen (PARC /2011/2831) was deposited at the Padmavathi herbarium of the Centre for future reference.
Preparation of aqueous extract
The shade-dried leaves were pulverized to a coarse powder which was used for extraction. The aqueous extract was prepared according to a previous method [9] . Briefly, 100 g of the powdered leaves was mixed with 500 mL of distilled water in a 1 L flask and boiled for 1 1 / 2 h. The extract was filtered using whatman No.1 filter paper after cooling it to 40°C. The filtrate was concentrated in a rotary evaporator under vacuum (40 °C) and stored at 4 °C until used. The yield was 8.23 %w/w.
Preparation of ethanol extract
Crude ethanolic extract of powered plants was prepared according to a previous method [10] in which 200 g of ground plant material was soaked in 500 ml of 70 % aqueous ethanol by cold maceration at room temperature for 72 h, after which the filtrate was collected through a piece of muslin cloth and then filter paper; the marc was subjected to the same procedure twice. The filtrate was concentrated in a rotary evaporator at 40 °C under reduced pressure to yield the crude extract. This extract was stored at 4 °C pending its use. The yield of the extract was 8.84 %w/w. The aqueous and alcohol extracts were subjected to preliminary phytochemical analyses using standard methods [11] .
Experimental animals
Male albino rats weighing 150 -200 g were used. The animals were fed standardized animal chow and water ad libitum. The rats were used after acclimatization under controlled conditions of temperature of 24 ± 2 °C, humidity of 50 ± 5 % and 10 -12 h of light and dark cycles for one week. The animals were housed individually in metabolic cages containing sterile paddy husk as bedding throughout the experiment. The toxicity and anti-urolithic experimental studies were conducted after obtaining the approval of the institutional Animal Ethical Committee, Padmavathi College of Pharmacy (approval ref.
no IECA/CBCSEA/2012/093). Animal experiments were performed in accordance with the guide for the humane care and use of laboratory animals [11] and CPCSEA guidelines of the Government of India.
Acute toxicity studies
Male albino rats were used for studies. The animal were fasted overnight, providing them with only water. Acute oral toxicity study was performed using both the aqueous and ethanol extracts (based on OECD guidelines) at dose range 250 to 2500 mg/kg [12] . If mortality was observed in two out of three animals, than the dose administered was assigned as toxic dose. If the mortality was observed in one animal, than the same dose was repeated again, and if mortality was not observed, the procedure was repeated for the higher dose, up to 2500 mg/kg. The animals were observed for body temperature, behavioral, neurological and autonomic profiles for 24 h [13] .
Animal studies
The animals were divided into seven groups of 6 animals each. Group I served as normal control and received regular rat feed and drinking water ad libitum. Ethylene glycol (0.75 %) in drinking water was fed to Groups II -VII for induction of renal calculi for 28 days. Group II served as lithiatic control and received vehicle (1% Tween 80); Group III received the standard antiurolithiatic drug, allopurinol (50 mg/kg bw, po) from the 15th to 28th day. Group IV received the aqueous extract (250mg/kg bw, po.) from the 15th day till 28th day and served as curative regimen (CR). Group V received the ethanolic extract (250mg/kg bw, po.) from 1st day till 28th day and served as CR. Group VI received the aqueous extract (250 mg/kg, p.o.) from the 15th to 28th day and served as preventive regimen (PR). Group VII received the ethanol extract (250 mg/kg, p.o.) from the 1st to 28th day and also served as PR. All the drugs were given once daily by oral route using gastric tube.
Urine analysis
The rats were kept separately in metabolic cages and 24h urine samples were collected on the 28th day. A drop of concentrated hydrochloric acid was added to the urine prior to storage at 4 °C, and then analysed for calcium and oxalate content by colorimetric procedure [14] and for phosphorus content by molybdenum blue reaction [15] . The collected urine samples were centrifuged at 3000 rpm for 10 min. After centrifugation, the urine samples were examined under light microscope to ensure the frequency, shape and size of the calcium oxalate crystals
Serum analysis
At the end of the treatment period, the animals were sacrificed by cervical dislocation under anaesthetia and blood was collected from the retro-orbital puncture of animal. Serum was separated by centrifugation at 10,000 g for 10 min analyzed for creatinine and urea nitrogen content using commercially available kits and uric acid by a colorimetric method [16] .
Histopathology
Three animals in each group were sacrificed at the end of the final urine collection. The kidneys were washed, weighed and fixed rapidly with 10 % neutralized formalin (pH7.4), embedded in paraffin, sliced 5 μm pieces; the slices were stained with hematoxylin and eosin and mounted in diphenyl xylene. Tissue slices were photographed using optical microscopy and the histopathological changes in kidney architecture observed [17] .
Biochemical analysis of kidney homogenate
Isolated kidneys were dried at 80 C in a hot air oven. A sample of 100 mg of the dried kidney was boiled in 10 ml of 1M hydrochloric acid for 30 min and homogenized. The homogenate was centrifuged at 2000 g for 10 min and the supernatant separated. The supernatant was analysed for calcium and oxalate content by a colorimetric procedure [14] as well as for phosphorus content in the kidney homogenate by molybdenum blue reaction [18] .
Statistical analysis
The data obtained were expressed as mean ± SD and analysed for differences using one-way ANOVA followed by Dunnet multiple comparison test using Graph Pad Prism software (GraphPad Software Inc, version 4.0.0.255).
RESULTS
The preliminary phytochemical study of Melia azedarach showed the presence of flavonoids and saponins in aqueous extract and alkaloids, carbohydrates, glycosides, saponins, steroids and triterpenoids in the ethanol extract of Melia azedarach leaves.
Acute toxicity
The extract showed neither mortality nor any visible clinical signs of general weakness in the animals. Hence, 2500 mg/kg was considered as LD 50 cut-off value and 250 mg/kg (1/10 of 2500 mg/kg) was taken as treatment dose based on the fixed-dose method of OECD guidelines.
Anti-urolithiatic activity
Chronic administration of ethylene glycol (0.75 %) in aqueous solution to the rats resulted in hyperoxaluria. Oxalate and calcium excretion in urine increased to 3.68 ± 0.01 and 4.50 ± 0.01 mg/24h respectively in calculi-induced animals compared to normal control group (Table 1 , Group II). However, administration of ethanol extract and aqueous extracts significantly (p < 0.01) reduced the elevated levels of calcium, oxalate, phosphate excretion in urine to 0.79 ± 0.01 and 1.09 ± 0.04 mg/24h, respectively (Table 1 , Groups IV -VII). Table 2 , Groups IV -VII).
The creatinine clearance of lithiatic control rats were decreased, but it was improved in standard drug and extract-treated groups. Serum analysis showed a significant increase (p < 0.01) in creatinine levels in lithiatic control rats when compared to normal rats (Group I). After treatment with ethanol extract, serum creatinine levels were restored to the normal value of 0.87 ± 0.01 mg/dl (Table 3 , Group VI).
Urine microscopy analysis revealed frequency and size of calcium oxalate crystals is larger in the urine of lithiatic group animals (Fig 1B) , when compared with control group (Fig 1A) . On the other hand, the ethanol and aqueous extracttreated groups showed significant reduction in frequency and size of calcium oxalate crystals compared with lithiatic group (Fig 1F and 1G ). The histopathological study of the kidneys from the rats in the normal control group (Group 1), presented a normal appearance with normal glomeruli, proximal and distal convoluted tubules without any inflammatory changes, normal blood vessels and no calcium oxalate depositions ( Figure. 2A) . In lithiatic control, there was presence of small slender pointed calcium oxalate crystals in lumen of proximal convoluted tubule.
Tubules were highly dilated and cystic tubules with sloughing of the tubular epithelial cells ( Figure 2B ). There were irregular calcium oxalate crystals in the lamina of the tubules which caused dilation of proximal tubules along with interstitial inflammation.
The aqueous extract-treated animals showed few crystals as well as appearance of slight edema and dilation in tubules ( Figure 2C ). Similarly, in animals administered ethanol extract, no crystals were observed and apparently retained normal morphology, tubular epithelial cells and glomeruli as in control group ( Figure 2D ). However, very mild degeneration of cells and cyst formation were observed. 
DISCUSSION
Increased urinary calcium is a factor favoring the nucleation and precipitation of calcium, oxalate or phosphate from urine and consequent crystal growth.
It has been reported that hyperabsorption of calcium is due to defective renal tubular reabsorption [16] . Stone formation in ethylene glycol-fed animals is caused by hyperoxaluria, which causes increased renal retention and excretion of oxalate [17] .
Evidence from earlier studies indicate that methylene glycol is metabolized to oxalate [20] . Enzymatic disturbances are causative factors of idiopathic hyperoxaluria, which causes increased renal retention and excretion of oxalate [18] . In this study, supplementation with ethanol extract of Melia azedarach, restored urinary phosphate level, thereby reducing the risk of stone formation and lower the levels of calcium as well as oxalate in urine.
The extracts hastened the process of dissolving the preformed stones in curative regimen and prevention of new stone formation in urinary system on prophylactic treatment, may be due to mild diuretic effect and antioxidant activity mild diuretic effect and antioxidant activity [22] .
Similar histopathological observations, earlier reported support, the presence of glomerular atrophy and deposition of crystals and attainment of normalcy of tubular epithelial cells and glomeruli when treated with plant extract [5] . In lithiatic control rats (Group II), marked renal damage is evidenced by the elevated serum levels of creatinine, uric acid and blood urea nitrogen. The significant elevated serum levels of blood urea nitrogen, creatinine and uric acid in lithiatic control animals may be due to the obstruction of the outflow of the urine by stones in urinary system. However, ethanol and aqueous extractrestored the elevated serum levels of creatinine, uric acid and blood urea nitrogen, the markers previously reported which affirms the potent antiurolithiatic activity of the extracts [4] . These results indicate the presence of calcium oxalate crystal aggregation inhibitory constituent(s) in the plant that interfere with crystal growth and aggregation; this probably is a pointer to a possible therapeutic strategy for the prevention of recurrent stone disease. The plant Melia azedarach extract have been reported to possess anti-inflammatory [23] and antimicrobial activities [24] , and this may complement its beneficial effect in urolithiasis, as infection and inflammation are likely to be associated with urolithiasis process.
CONCLUSION
The findings of this study demonstrate that the aqueous and ethanol leaf extracts of Melia azedarach Linn possess potent antiurolithiatic activity against ethylene glycol-induced calcium oxalate urolithiasis in rats. The antiurolithiatic effects may be mediated possibly through a combination of calcium oxalate crystal inhibition, as well as via diuretic, antioxidant, renal epithelial cell protective, and hyper-magneseuric effects. Further investigation on its safety profile, antioxidant activity and diuretic effect is essential to establish its potential for clinical use.
